In lung cancer, hepatoblastoma, melanoma, and osteosarcoma, OIP5-AS1 acts as a ceRNA and regulates miRNA and target genes to promote proliferation, metastasis and drug resistance [36–39]. The gene discussed is OIP5; the disease is lung cancer.